The zinc finger domain of IKKγ (NEMO) protein in health and disease

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 10, 2010, Pages 2404-2414

  Shifera, Amde Selassie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ectodermal dysplasia; Hyper IgM syndrome; IKKgamma; Immune deficiency; NEMO; Ubiquitination; Zinc finger

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ZINC FINGER PROTEIN;

ANIMAL; ARTICLE; ECTODERMAL DYSPLASIA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPER IGM SYNDROME; IMMUNOLOGY; METABOLISM; MOUSE; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN DOMAIN; RAT; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ECTODERMAL DYSPLASIA; GENE EXPRESSION REGULATION; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME; I-KAPPA B KINASE; MICE; MUTATION; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITINATION; ZINC FINGERS;

EID: 77958517570     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01054.x     Document Type: Article

References (89)

1. Yamaoka S, Courtois G, Bessia C, et al Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998; 93: 1231-40.
2. Rothwarf DM, Zandi E, Natoli G, et al IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998; 395: 297-300.
3. Mercurio F, Murray BW, Shevchenko A, et al IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol. 1999; 19: 1526-38.
4. Li Y, Kang J, Friedman J, et al Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci USA. 1999; 96: 1042-7.
5. DiDonato JA, Hayakawa M, Rothwarf DM, et al A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997; 388: 548-54.
6. Mercurio F, Zhu H, Murray BW, et al IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 1997; 278: 860-6.
7. Zandi E, Rothwarf DM, Delhase M, et al The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997; 91: 243-52.
8. Regnier CH, Song HY, Gao X, et al Identification and characterization of an IkappaB kinase. Cell. 1997; 90: 373-83.
9. Woronicz JD, Gao X, Cao Z, et al IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science. 1997; 278: 866-9.
10. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 1996; 84: 853-62.
11. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998; 16: 225-60.
12. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996; 14: 649-83.
13. Delhalle S, Blasius R, Dicato M, et al A beginner's guide to NF-kappaB signaling pathways. Ann N Y Acad Sci. 2004; 1030: 1-13.
14. Huang H, Calderon TM, Berman JW, et al Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun. 1999; 67: 5434-40.
15. Li X, Stark GR. NFkappaB-dependent signaling pathways. Exp Hematol. 2002; 30: 285-96.
16. Li J, Peet GW, Balzarano D, et al Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem. 2001; 276: 18579-90.
17. Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. 2006; 210: 171-86.
18. Dejardin E, Droin NM, Delhase M, et al The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 2002; 17: 525-35.
19. Eliopoulos AG, Caamano JH, Flavell J, et al Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene. 2003; 22: 7557-69.
20. He KL, Ting AT. Essential role for IKKgamma/NEMO in TCR-induced IL-2 expression in Jurkat T cells. Eur J Immunol. 2003; 33: 1917-24.
21. Chen F, Bhatia D, Chang Q, et al Finding NEMO by K63-linked polyubiquitin chain. Cell Death Differ. 2006; 13: 1835-8.
22. Cordier F, Grubisha O, Traincard F, et al The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem. 2009; 284: 2902-7.
23. Tokunaga F, Sakata S, Saeki Y, et al Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol. 2009; 11: 123-32.
24. Jin DY, Jeang KT. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. J Biomed Sci. 1999; 6: 115-20.
25. Makris C, Godfrey VL, Krahn-Senftleben G, et al Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell. 2000; 5: 969-79.
26. Smahi A, Courtois G, Vabres P, et al Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000; 405: 466-72.
27. Fusco F, Mercadante V, Miano MG, et al Multiple regulatory regions and tissue-specific transcription initiation mediate the expression of NEMO/IKKgamma gene. Gene. 2006; 383: 99-107.
28. Aradhya S, Woffendin H, Jakins T, et al A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001; 10: 2171-9.
29. Rudolph D, Yeh WC, Wakeham A, et al Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 2000; 14: 854-62.
30. Schmidt-Supprian M, Bloch W, Courtois G, et al NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell. 2000; 5: 981-92.
31. Schmidt-Supprian M, Courtois G, Tian J, et al Mature T cells depend on signaling through the IKK complex. Immunity. 2003; 19: 377-89.
32. Nishikomori R, Akutagawa H, Maruyama K, et al X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood. 2004; 103: 4565-72.
33. Pasparakis M, Schmidt-Supprian M, Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med. 2002; 196: 743-52.
34. Kim S, La Motte-Mohs RN, Rudolph D, et al The role of nuclear factor-kappaB essential modulator (NEMO) in B cell development and survival. Proc Natl Acad Sci USA. 2003; 100: 1203-8.
35. Rottenberg S, Schmuckli-Maurer J, Grimm S, et al Characterization of the bovine IkappaB kinases (IKK)alpha and IKKbeta, the regulatory subunit NEMO and their substrate IkappaBalpha. Gene. 2002; 299: 293-300.
36. Ye J, Xie X, Tarassishin L, et al Regulation of the NF-kappaB activation pathway by isolated domains of FIP3/ IKKgamma, a component of the IkappaB-alpha kinase complex. J Biol Chem. 2000; 275: 9882-9.
37. Sun SC, Harhaj EW, Xiao G, et al Activation of I-kappaB kinase by the HTLV type 1 Tax protein: mechanistic insights into the adaptor function of IKKgamma. AIDS Res Hum Retroviruses. 2000; 16: 1591-6.
38. Iha H, Kibler KV, Yedavalli VR, et al Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling. Oncogene. 2003; 22: 8912-23.
39. Chu ZL, Shin YA, Yang JM, et al IKKgamma mediates the interaction of cellular IkappaB kinases with the Tax transforming protein of human T cell leukemia virus type 1. J Biol Chem. 1999; 274: 15297-300.
40. Harhaj EW, Sun SC. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem. 1999; 274: 22911-4.
41. Li XH, Fang X, Gaynor RB. Role of IKKgamma/nemo in assembly of the Ikappa B kinase complex. J Biol Chem. 2001; 276: 4494-500.
42. Marienfeld RB, Palkowitsch L, Ghosh S. Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Mol Cell Biol. 2006; 26: 9209-19.
43. Smahi A, Courtois G, Rabia SH, et al The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002; 11: 2371-5.
44. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol. 2002; 47: 169-87.
45. Courtois G, Smahi A, Israel A. NEMO/IKK gamma: linking NF-kappa B to human disease. Trends Mol Med. 2001; 7: 427-30.
46. Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene. 2006; 25: 6831-43.
47. Durandy A, Peron S, Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol. 2006; 18: 369-76.
48. Nelson DL. NEMO, NFkappaB signaling and incontinentia pigmenti. Curr Opin Genet Dev. 2006; 16: 282-8.
49. Uzel G. The range of defects associated with nuclear factor kappaB essential modulator. Curr Opin Allergy Clin Immunol. 2005; 5: 513-8.
50. McDonald DR, Janssen R, Geha R. Lessons learned from molecular defects in nuclear factor kappaB dependent signaling. Microbes Infect. 2006; 8: 1151-6.
51. Wisniewski SA, Kobielak A, Trzeciak WH, et al Recent advances in understanding of the molecular basis of anhidrotic ectodermal dysplasia: discovery of a ligand, ectodysplasin A and its two receptors. J Appl Genet. 2002; 43: 97-107.
52. Puel A, Picard C, Ku CL, et al Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004; 16: 34-41.
53. Orange JS, Jain A, Ballas ZK, et al The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol. 2004; 113: 725-33.
54. Doffinger R, Smahi A, Bessia C, et al X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001; 27: 277-85.
55. Aradhya S, Courtois G, Rajkovic A, et al Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet. 2001; 68: 765-71.
56. Zonana J, Elder ME, Schneider LC, et al A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000; 67: 1555-62.
57. Jain A, Ma CA, Liu S, et al Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001; 2: 223-8.
58. Lee WI, Torgerson TR, Schumacher MJ, et al Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005; 105: 1881-90.
59. Orange JS, Brodeur SR, Jain A, et al Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest. 2002; 109: 1501-9.
60. Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev. 2005; 203: 21-37.
61. Schmid JM, Junge SA, Hossle JP, et al Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation. Pediatrics. 2006; 117: e1049-56.
62. Sitton JE, Reimund EL. Extramedullary hematopoiesis of the cranial dura and anhidrotic ectodermal dysplasia. Neuropediatrics. 1992; 23: 108-10.
63. Chang TT, Behshad R, Brodell RT, et al A male infant with anhidrotic ectodermal dysplasia/immunodeficiency accompanied by incontinentia pigmenti and a mutation in the NEMO pathway. J Am Acad Dermatol. 2008; 58: 316-20.
64. Mancini AJ, Lawley LP, Uzel G. X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis. Arch Dermatol. 2008; 144: 342-6.
65. Niehues T, Reichenbach J, Neubert J, et al Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol. 2004; 114: 1456-62.
66. Orstavik KH, Kristiansen M, Knudsen, GP, et al Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A. 2006; 140: 31-9.
67. Jain A, Ma CA, Lopez-Granados E, et al Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J Clin Invest. 2004; 114: 1593-602.
68. Miller J, McLachlan AD, Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 1985; 4: 1609-14.
69. Iuchi S. Three classes of C2H2 zinc finger proteins. Cell Mol Life Sci. 2001; 58: 625-35.
70. Wolfe SA, Nekludova L, Pabo CO. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct. 2000; 29: 183-212.
71. Gamsjaeger R, Liew CK, Loughlin FE, et al Sticky fingers: zinc-fingers as protein-recognition motifs. Trends Biochem Sci. 2007; 32: 63-70.
72. Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001; 11: 39-46.
73. Ladomery M, Dellaire G. Multifunctional zinc finger proteins in development and disease. Ann Hum Genet. 2002; 66: 331-42.
74. Temmerman ST, Ma CA, Borges L, et al Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination. Blood. 2006; 108: 2324-31.
75. Yang F, Yamashita J, Tang E, et al The zinc finger mutation C417R of I-kappa B kinase gamma impairs lipopolysaccharide- and TNF-mediated NF-kappa B activation through inhibiting phosphorylation of the I-kappa B kinase beta activation loop. J Immunol. 2004; 172: 2446-52.
76. Cordier F, Vinolo E, Veron M, et al Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. J Mol Biol. 2008; 377: 1419-32.
77. Huang TT, Feinberg SL, Suryanarayanan S, et al The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors. Mol Cell Biol. 2002; 22: 5813-25.
78. Shifera AS, Horwitz MS. Mutations in the zinc finger domain of IKK gamma block the activation of NF-kappa B and the induction of IL-2 in stimulated T lymphocytes. Mol Immunol. 2008; 45: 1633-45.
79. Tang ED, Wang CY, Xiong Y, et al A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem. 2003; 278: 37297-305.
80. Makris C, Roberts JL, Karin M. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation. Mol Cell Biol. 2002; 22: 6573-81.
81. Carter RS, Geyer BC, Xie M, et al Persistent activation of NF-kappa B by the Tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma. J Biol Chem. 2001; 276: 24445-8.
82. Carter RS, Pennington KN, Ungurait BJ, et al In vivo identification of inducible phosphoacceptors in the IKKgamma/ NEMO subunit of human IkappaB kinase. J Biol Chem. 2003; 278: 19642-8.
83. Laplantine E, Fontan E, Chiaravalli J, et al NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 2009; 28: 2885-95.
84. Rahighi S, Ikeda F, Kawasaki M, et al Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell. 2009; 136: 1098-109.
85. Kulathu Y, Akutsu M, Bremm A, et al Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat Struct Mol Biol. 2009; 16: 1328-30.
86. Sato Y, Yoshikawa A, Yamashita M, et al Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3. EMBO J. 2009; 28: 3903-9.
87. Wu CJ, Conze DB, Li T, et al Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol. 2006; 8: 398-406.
88. Ea CK, Deng L, Xia ZP, et al Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006; 22: 245-57.
89. Wu CJ, Ashwell JD. NEMO recognition of ubiquitinated Bcl10 is required for T cell receptor-mediated NF-kappaB activation. Proc Natl Acad Sci USA. 2008; 105: 3023-8.